Compare FNWD & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNWD | QTRX |
|---|---|---|
| Founded | 1994 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.2M | 160.0M |
| IPO Year | 1996 | 2017 |
| Metric | FNWD | QTRX |
|---|---|---|
| Price | $32.98 | $3.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $37.50 | $6.00 |
| AVG Volume (30 Days) | 5.9K | ★ 1.5M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | N/A | ★ $37,632,000.00 |
| Revenue This Year | $17.40 | $25.49 |
| Revenue Next Year | $5.44 | $10.04 |
| P/E Ratio | $62.85 | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $26.46 | $2.40 |
| 52 Week High | $39.99 | $8.77 |
| Indicator | FNWD | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.60 | 50.61 |
| Support Level | $32.38 | $2.95 |
| Resistance Level | $33.04 | $3.65 |
| Average True Range (ATR) | 0.90 | 0.24 |
| MACD | 0.18 | 0.07 |
| Stochastic Oscillator | 43.78 | 84.25 |
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.